TA Associates may take part of Carlyle Group's stake in Claris Lifesciences - reports

According to local reports, Carlyle Group invested approximately $20 million into Claris in 2006 for a 15% stake. That capital came through its Carlyle Asia Growth Partners III fund. The news comes as TA is additionally looking into another deal with an unnamed healthcare and pharmaceuticals company. Earlier reports suggested that TA is looking to expand its influence in these areas, and both the deals could be worth a collective $100 million.

Claris reported total income for the year ending 31 December 2009 as INR7,594 million ($162.7 million), and a net profit after taxation as INR1,249 million ($26.8 million). The company, which is further looking to list on the Bombay Stock Exchange, claims approximately 1,550 worldwide employees, of which nearly 1,500 are in India.

The Boston-based firm, which claims $16 billion under its management, has this year invested $45 million in Indian mobile handset business Micromax Informatics Ltd, and, in July, the firm further appointed Standard Chartered Private Equity director Dhiraj Poddar for the same role in its Mumbai office.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Save this article  
• Send to  

• Topics
• Healthcare
• South Asia
• The Carlyle Group
• TA Associates